Lincoln Capital Corp’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $498K | Sell |
1,376
-567
| -29% | -$194K | 0.16% | 69 |
|
|
2026
Q1 | $684K | Sell |
1,943
-292
| -13% | -$104K | 0.25% | 58 |
|
|
2025
Q4 | $731K | Hold |
2,235
| – | – | 0.26% | 56 |
|
|
2025
Q3 | $631K | Buy |
2,235
+508
| +29% | +$147K | 0.23% | 55 |
|
|
2025
Q2 | $482K | Buy |
1,727
+453
| +36% | +$128K | 0.19% | 56 |
|
|
2025
Q1 | $397K | Sell |
1,274
-439
| -26% | -$130K | 0.17% | 61 |
|
|
2024
Q4 | $447K | Buy |
1,713
+80
| +5% | +$23.7K | 0.18% | 61 |
|
|
2024
Q3 | $526K | Sell |
1,633
-310
| -16% | -$101K | 0.21% | 51 |
|
|
2024
Q2 | $607K | Buy |
1,943
+195
| +11% | +$57.3K | 0.26% | 52 |
|
|
2024
Q1 | $497K | Hold |
1,748
| – | – | 0.22% | 47 |
|
|
2023
Q4 | $503K | Hold |
1,748
| – | – | 0.25% | 47 |
|
|
2023
Q3 | $470K | Sell |
1,748
-270
| -13% | -$67.4K | 0.25% | 45 |
|
|
2023
Q2 | $448K | Hold |
2,018
| – | – | 0.23% | 45 |
|
|
2023
Q1 | $488K | Buy |
2,018
+100
| +5% | +$24.5K | 0.28% | 41 |
|
|
2022
Q4 | $504K | Hold |
1,918
| – | – | 0.31% | 39 |
|
|
2022
Q3 | $432K | Hold |
1,918
| – | – | 0.29% | 43 |
|
|
2022
Q2 | $467K | Buy |
1,918
+165
| +9% | +$40.4K | 0.3% | 47 |
|
|
2022
Q1 | $424K | Sell |
1,753
-833
| -32% | -$191K | 0.22% | 49 |
|
|
2021
Q4 | $582K | Sell |
2,586
-663
| -20% | -$140K | 0.28% | 45 |
|
|
2021
Q3 | $691K | Sell |
3,249
-14,993
| -82% | -$3.45M | 0.37% | 41 |
|
|
2021
Q2 | $4.45M | Sell |
18,242
-454
| -2% | -$112K | 2.54% | 13 |
|
|
2021
Q1 | $4.65M | Sell |
18,696
-3,631
| -16% | -$866K | 2.9% | 12 |
|
|
2020
Q4 | $5.13M | Sell |
22,327
-647
| -3% | -$149K | 3.37% | 9 |
|
|
2020
Q3 | $5.84M | Sell |
22,974
-278
| -1% | -$68.9K | 4.27% | 6 |
|
|
2020
Q2 | $5.48M | Buy |
23,252
+347
| +2% | +$79.2K | 4.29% | 7 |
|
|
2020
Q1 | $4.64K | Buy |
22,905
+996
| +5% | +$218K | 2.08% | 9 |
|
|
2019
Q4 | $5.28M | Sell |
21,909
-339
| -2% | -$74.7K | 3.92% | 10 |
|
|
2019
Q3 | $4.3M | Buy |
22,248
+765
| +4% | +$147K | 3.64% | 12 |
|
|
2019
Q2 | $3.96M | Buy |
21,483
+58
| +0.3% | +$10.4K | 3.49% | 11 |
|
|
2019
Q1 | $4.07M | Buy |
21,425
+131
| +0.6% | +$25K | 3.68% | 9 |
|
|
2018
Q4 | $4.14M | Sell |
21,294
-596
| -3% | -$116K | 3.82% | 8 |
|
|
2018
Q3 | $4.54M | Buy |
21,890
+6,478
| +42% | +$1.28M | 3.77% | 10 |
|
|
2018
Q2 | $2.85M | Sell |
15,412
-7,037
| -31% | -$1.24M | 2.64% | 20 |
|
|
2018
Q1 | $3.83M | Buy |
22,449
+4,605
| +26% | +$845K | 3.56% | 10 |
|
|
2017
Q4 | $3.1M | Sell |
17,844
-636
| -3% | -$113K | 2.65% | 15 |
|
|
2017
Q3 | $3.45M | Buy |
18,480
+664
| +4% | +$118K | 3.08% | 17 |
|
|
2017
Q2 | $3.07M | Sell |
17,816
-25
| -0.1% | -$4.07K | 2.71% | 18 |
|
|
2017
Q1 | $2.93M | Buy |
17,841
+1,464
| +9% | +$243K | 2.61% | 18 |
|
|
2016
Q4 | $2.4M | Buy |
+16,377
| New | +$2.46M | 2.31% | 21 |
|
Other funds holding AMGN
Lincoln Capital Corp's AMGN Position: Q2 2026 in Review
Lincoln Capital Corp reduced its Amgen (AMGN) stake by 29% in Q2 2026, selling an estimated $194K and leaving 1,376 shares worth $498K. The position accounts for 0.16% of the portfolio, ranked #69.
Lincoln Capital Corp first reported a position in AMGN in Q4 2016 and has held it in 39 quarters since. The position peaked at $5.84M in Q3 2020. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Lincoln Capital Corp held 1,376 shares of Amgen worth $498K as of Q2 2026.
- Lincoln Capital Corp sold 567 Amgen shares in Q2 2026, an estimated $194K.
- Amgen made up 0.16% of Lincoln Capital Corp's portfolio in Q2 2026, its #69 holding.
- Lincoln Capital Corp first reported a position in Amgen in Q4 2016 and has held it in 39 quarters since.
- Lincoln Capital Corp's Amgen position peaked at $5.84M in Q3 2020.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Lincoln Capital Corp's 13F filing for Q2 2026, filed 16 Jul 2026.